ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · IEX Real-Time Price · USD
116.89
-0.11 (-0.09%)
Sep 28, 2023, 10:47 AM EDT - Market open
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,280 | 1,316 | 1,271 | 1,266 | 1,400 | 1,293 | 379.37 | 341.67 | 309.26 | 313.72 | Upgrade
|
| Revenue Growth (YoY) | 73.21% | 3.56% | 0.38% | -9.56% | 8.31% | 240.72% | 11.04% | 10.48% | -1.42% | -1.00% | Upgrade
|
| Cost of Revenue | 1,582 | 824.82 | 809.51 | 794.34 | 830.01 | 866.52 | 177.97 | 160.87 | 157.86 | 158.98 | Upgrade
|
| Gross Profit | 697.76 | 491.49 | 461.5 | 471.86 | 570.03 | 426.1 | 201.4 | 180.8 | 151.4 | 154.73 | Upgrade
|
| Selling, General & Admin | 608.35 | 302.58 | 283.95 | 276.98 | 320 | 302.17 | 89.43 | 83.22 | 88.94 | 89.01 | Upgrade
|
| Research & Development | 92.98 | 47.5 | 42.95 | 48.61 | 52.87 | 51.25 | 12.96 | 15.71 | 18.33 | 12.41 | Upgrade
|
| Other Operating Expenses | 71.42 | 18.16 | 27.43 | 86.31 | 147 | 77.97 | 16.08 | 13.3 | 5.09 | 1.37 | Upgrade
|
| Operating Expenses | 772.75 | 368.25 | 354.34 | 411.9 | 519.87 | 431.39 | 118.46 | 112.23 | 112.36 | 102.78 | Upgrade
|
| Operating Income | -74.99 | 123.25 | 107.16 | 59.96 | 50.16 | -5.29 | 82.94 | 68.57 | 39.04 | 51.95 | Upgrade
|
| Interest Expense / Income | 66.38 | -1.98 | -1.92 | 0.55 | 0.71 | 2.05 | 0.12 | 0.04 | 0 | 0 | Upgrade
|
| Other Expense / Income | -26.96 | 2.04 | 11.59 | -55.3 | 27.07 | -58.62 | -2.34 | -1.17 | -0.76 | -0.77 | Upgrade
|
| Pretax Income | -114.41 | 123.19 | 97.49 | 114.71 | 22.37 | 51.28 | 85.16 | 69.7 | 39.79 | 52.71 | Upgrade
|
| Income Tax | -40.12 | 20.05 | 10.62 | 13.67 | -6.42 | -17.36 | 22.08 | 24.71 | 13.46 | 12.3 | Upgrade
|
| Net Income | -74.29 | 103.14 | 86.87 | 101.04 | 28.79 | 68.64 | 63.08 | 44.99 | 26.34 | 40.42 | Upgrade
|
| Net Income Growth | - | 18.72% | -14.02% | 250.90% | -58.05% | 8.81% | 40.23% | 70.82% | -34.84% | -2.09% | Upgrade
|
| Shares Outstanding (Basic) | 24 | 21 | 21 | 21 | 20 | 20 | 16 | 16 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 22 | 22 | 22 | 22 | 21 | 17 | 16 | 16 | 15 | Upgrade
|
| Shares Change | 9.58% | 0.88% | 0.21% | -0.26% | 3.56% | 20.89% | 4.60% | 5.43% | 2.44% | 3.73% | Upgrade
|
| EPS (Basic) | -3.11 | 4.86 | 4.16 | 4.90 | 1.41 | 3.50 | 3.90 | 2.84 | 1.72 | 2.75 | Upgrade
|
| EPS (Diluted) | -3.11 | 4.74 | 4.02 | 4.69 | 1.33 | 3.29 | 3.66 | 2.73 | 1.68 | 2.65 | Upgrade
|
| EPS Growth | - | 17.91% | -14.29% | 252.63% | -59.57% | -10.11% | 34.07% | 62.50% | -36.60% | -5.36% | Upgrade
|
| Free Cash Flow | -160.47 | 186.59 | 128.54 | -4.09 | 60.2 | 74.74 | 65.39 | 53.85 | 48.75 | 46.28 | Upgrade
|
| Free Cash Flow Per Share | -6.72 | 8.80 | 6.15 | -0.20 | 2.95 | 3.81 | 4.04 | 3.40 | 3.19 | 3.15 | Upgrade
|
| Gross Margin | 30.60% | 37.34% | 36.31% | 37.27% | 40.72% | 32.96% | 53.09% | 52.92% | 48.96% | 49.32% | Upgrade
|
| Operating Margin | -3.29% | 9.36% | 8.43% | 4.74% | 3.58% | -0.41% | 21.86% | 20.07% | 12.62% | 16.56% | Upgrade
|
| Profit Margin | -3.26% | 7.84% | 6.83% | 7.98% | 2.06% | 5.31% | 16.63% | 13.17% | 8.52% | 12.88% | Upgrade
|
| Free Cash Flow Margin | -7.04% | 14.18% | 10.11% | -0.32% | 4.30% | 5.78% | 17.24% | 15.76% | 15.76% | 14.75% | Upgrade
|
| Effective Tax Rate | - | 16.28% | 10.90% | 11.92% | -28.69% | -33.85% | 25.93% | 35.46% | 33.82% | 23.33% | Upgrade
|
| EBITDA | 210.77 | 220.5 | 190.42 | 200.47 | 97.82 | 119.9 | 104.33 | 87.81 | 59.24 | 72.22 | Upgrade
|
| EBITDA Margin | 9.24% | 16.75% | 14.98% | 15.83% | 6.99% | 9.28% | 27.50% | 25.70% | 19.16% | 23.02% | Upgrade
|
| Depreciation & Amortization | 258.8 | 99.29 | 94.85 | 85.21 | 74.74 | 66.57 | 19.05 | 18.07 | 19.45 | 19.51 | Upgrade
|
| EBIT | -48.03 | 121.2 | 95.57 | 115.26 | 23.08 | 53.33 | 85.28 | 69.74 | 39.79 | 52.71 | Upgrade
|
| EBIT Margin | -2.11% | 9.21% | 7.52% | 9.10% | 1.65% | 4.13% | 22.48% | 20.41% | 12.87% | 16.80% | Upgrade
|
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).